Pharma Market Access Insights - from Petauri Evidence

64 Avsnitt

1. Market access in the German speaking markets

   Publicerades: 2023-08-29
2. The role of nursing in driving digital change in the NHS

   Publicerades: 2023-07-26
3. Market access for digital therapies and digital medicines

   Publicerades: 2023-07-19
4. A global market access journey in cannabinoid pharmaceuticals

   Publicerades: 2023-06-17
5. Primary Care and ICBs – what is the next step in the integration journey?

   Publicerades: 2023-05-15
6. Data-led transformation in the NHS - partnering to optimise patient care

   Publicerades: 2023-03-31
7. Innovating for better health – research, collaboration and innovation in the NHS

   Publicerades: 2023-03-07
8. Healthcare, economics and society – unlocking NHS collaboration

   Publicerades: 2023-01-30
9. Specialised Commissioning in the NHS – What do you need to know now

   Publicerades: 2023-01-13
10. Why are we waiting? - Pressures facing the NHS and how to deliver change

    Publicerades: 2022-11-29
11. Priority setting in primary care - NHS insights

    Publicerades: 2022-10-18
12. Integrated Care Systems go live in the NHS - reflections after 3 weeks

    Publicerades: 2022-08-09
13. Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role

    Publicerades: 2022-08-01
14. Transforming systems and care pathways for an integrated NHS

    Publicerades: 2022-06-21
15. Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers

    Publicerades: 2022-05-04
16. Population to Person: How will the NHS translate population health management into impactful, person-centred service change?

    Publicerades: 2022-03-15
17. Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?

    Publicerades: 2022-02-11
18. The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion

    Publicerades: 2022-01-17
19. Optimising the NHS – How will medicines be valued in integrated systems?

    Publicerades: 2021-12-21
20. Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe

    Publicerades: 2021-11-29